Chronic myeloid leukemia: reminiscences and dreams
作者： T. I. Mughal , J. P. Radich , M. W. Deininger , J. F. Apperley , T. P. Hughes
DOI: 10.3324/HAEMATOL.2015.139337
关键词: Myelogenous 、 Leukemia 、 ABL 、 Transplantation 、 Philadelphia chromosome 、 Myeloid leukemia 、 Psychoanalysis 、 Tribute 、 Medicine 、 Praise 、 Gerontology
摘要: … between leukemia cell lines and primary leukemia cells, limiting the applicability of conclusions derived from in vitro studies. Experiments on primary cells and murine models identified …
haematologica.org
core.ac.uk
sahmriresearch.org
elsevier.com参考文章(194)
R Salgia, M Sattler, E Pisick, JL Li, JD Griffin, None, P210BCR/ABL INDUCES FORMATION OF COMPLEXES CONTAINING FOCAL ADHESION PROTEINS AND THE PROTOONCOGENE PRODUCT P120C-CBL Experimental Hematology. ,vol. 24, pp. 310- 313 ,(1996)
HJ Kolb, J Mittermuller, C Clemm, E Holler, G Ledderose, G Brehm, M Heim, W Wilmanns, Donor Leukocyte Transfusions for Treatment of Recurrent Chronic Myelogenous Leukemia in Marrow Transplant Patients Blood. ,vol. 76, pp. 2462- 2465 ,(1990) , 10.1182/BLOOD.V76.12.2462.2462
Christian Sillaber, Franck Gesbert, David A. Frank, Martin Sattler, James D. Griffin, STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells Blood. ,vol. 95, pp. 2118- 2125 ,(2000) , 10.1182/BLOOD.V95.6.2118
TP Hughes, GJ Morgan, P Martiat, JM Goldman, Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood. ,vol. 77, pp. 874- 878 ,(1991) , 10.1182/BLOOD.V77.4.874.874
R Hehlmann, H Heimpel, J Hasford, HJ Kolb, H Pralle, DK Hossfeld, W Queisser, H Loffler, B Heinze, A Georgii, Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group Blood. ,vol. 82, pp. 398- 407 ,(1993) , 10.1182/BLOOD.V82.2.398.398
A.G. Elefanty, I.K. Hariharan, S. Cory, bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. The EMBO Journal. ,vol. 9, pp. 1069- 1078 ,(1990) , 10.1002/J.1460-2075.1990.TB08212.X
Sante Tura, Michele Baccarani, Eliana Zuffa, Domenico Russo, Renato Fanin, Alfonso Zaccaria, Mauro Fiacchini, None, Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. The New England Journal of Medicine. ,vol. 330, pp. 820- 825 ,(1994) , 10.1056/NEJM199403243301204
H Waldmann, J Hows, J F Apperley, G Hale, E C Gordon-Smith, R E Marcus, Y Rombos, C Tsatalas, A W Goolden, L Jones, Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. Bone Marrow Transplantation. ,vol. 1, pp. 53- 66 ,(1986)
R Q Le, X Tian, N A Jain, K Lu, S Ito, D A Draper, P Anandi, C S Hourigan, N Dunavin, A John Barrett, M Battiwalla, Clinical comorbidity predictive measures in ex vivo T-cell-depleted allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. ,vol. 50, pp. 1138- 1140 ,(2015) , 10.1038/BMT.2015.112
Frederick R. Appelbaum, Alan E. Lichtin, Hagop M. Kantarjian, Rüdiger Hehlmann, Sante Tura, Moshe Talpaz, Francois Guilhot, John M. Goldman, Charles Bennett, Steven H. Woolf, Richard T. Silver, James Anderson, An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: Developed for the American Society of Hematology Blood. ,vol. 94, pp. 1517- 1536 ,(1999) , 10.1182/BLOOD.V94.5.1517